Viewing Study NCT00924092


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-30 @ 5:04 AM
Study NCT ID: NCT00924092
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2009-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module